Growth retardation in children with chronic renal failure

BD Kuizon, IB Salusky - Journal of bone and mineral research, 1999 - academic.oup.com
Growth retardation is a major obstacle to full rehabilitation of children with chronic renal
failure (CRF). Several factors have been identified as contributors to impaired linear growth …

Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD

BD Kuizon, WG Goodman, H Jüppner, I Boechat… - Kidney international, 1998 - Elsevier
Diminished linear growth during intermittent calcitriol therapy in children undergoing CCPD.
Daily calcitriol therapy has been reported to improve linear growth in children with renal …

[HTML][HTML] Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration

IB Salusky, BD Kuizon, TR Belin, JA Ramirez… - Kidney international, 1998 - Elsevier
Intermittent calcitriol therapy in secondary hyperparathyroidism: A comparison between oral
and intraperitoneal administration. Background Intermittent oral or intravenous doses of …

Intermittent calcitriol therapy and growth in children with chronic renal failure

BD Kuizon, IB Salusky - Mineral and electrolyte metabolism, 1998 - karger.com
Abstract Intermittent calcitriol (1, 25D) therapy has been used for the management of
secondary hyperparathyroidism in children with chronic renal failure; however, the …

Paricalcitol versus calcitriol treatment for hyperparathyroidism in pediatric hemodialysis patients

W Seeherunvong, O Nwobi, CL Abitbol, J Chandar… - Pediatric …, 2006 - Springer
Secondary hyperparathyroidism (SHPT) remains a treatment dilemma in pediatric dialysis
patients. Recent experience with paricalcitol (P), a vitamin D analogue, in adults with SHPT …

Calcitriol pulse therapy is not more effective than daily calcitriol therapy in controlling secondary hyperparathyroidism in children with chronic renal failure

G Ardissino, CP Schmitt, S Testa, A Claris-Appiani… - Pediatric …, 2000 - Springer
Calcitriol oral pulse therapy has been suggested as the treatment of choice for secondary
hyperparathyroidism, but its efficacy and safety are still under discussion. The present …

[HTML][HTML] Diálisis peritoneal crónica pediátrica en Chile: Estudio multicéntrico

Á Delucchi, MA Contreras, A Bidegain… - Revista chilena de …, 2002 - SciELO Chile
Introducción: La iniciación de la Diálisis Peritoneal Continua Ambulatoria en Chile desde
1995, ha mejorado el manejo del paciente pediátrico en insuficiencia renal crónica terminal …

A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone secretion and calcaemic …

M Hirata, K Endo, K Katsumata… - Nephrology Dialysis …, 2002 - academic.oup.com
Abstract Background. Since Slatopolsky et al.(J Clin Invest 1984; 74: 2136–2143) reported
the effect of active vitamin D, 1, 25-dihydroxyvitamin D3 (1, 25 (OH) 2D3), on secondary …

Implications of intermittent calcitriol therapy on growth and secondary hyperparathyroidism

IB Salusky, WG Goodman, BD Kuizon - Pediatric Nephrology, 2000 - Springer
Secondary hyperparathyroidism is the most common skeletal lesion in pediatric patients
undergoing maintenance dialysis. The present review summarizes a prospective …

Management of end-stage renal disease in children

PS Smith - Annals of Pharmacotherapy, 1998 - journals.sagepub.com
OBJECTIVE: To review the medical literature on management of end-stage renal disease
(ESRD) and its complications in the pediatric patient. DATA SOURCES AND STUDY …